Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Rigel Pharmaceuticals Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 194
- +26 vs. Q3 2025
- Shares held
- 16.1M
- +1.15M (+7.7%) vs. Q3 2025
- Total value
- $690.5M
- +$265.9M (+62.6%) vs. Q3 2025
- New holders
- 51
- 67 more added
- Sold out
- 25
- 63 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 155 | $640.4M |
| Q1 2026 | 159 | $432.8M |
| Q4 2025 | 194 | $690.5M |
| Q3 2025 | 169 | $425.6M |
| Q2 2025 | 126 | $260.2M |
| Q1 2025 | 123 | $250.2M |
| Q4 2024 | 122 | $203.0M |
| Q3 2024 | 93 | $192.6M |
| Q2 2024 | 91 | $85.4M |
| Q1 2024 | 117 | $164.3M |
| Q4 2023 | 113 | $154.5M |
| Q3 2023 | 106 | $114.8M |
| Q2 2023 | 118 | $142.7M |
| Q1 2023 | 125 | $148.6M |
| Q4 2022 | 118 | $163.1M |
| Q3 2022 | 138 | $150.3M |
| Q2 2022 | 135 | $157.2M |
| Q1 2022 | 163 | $405.7M |
| Q4 2021 | 162 | $365.9M |
| Q3 2021 | 163 | $499.6M |
| Q2 2021 | 160 | $614.5M |
| Q1 2021 | 152 | $493.1M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −22,600−100.0% | Sold out |
| PharVision Advisers, LLC | 0 | $0 | 0.00% | −20,522−100.0% | Sold out |
| NJ State Employees Deferred Compensation Plan | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −19,330−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,489−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Advantage Alpha Capital Partners LP | 0 | $0 | 0.00% | −11,804−100.0% | Sold out |
| Massar Capital Management, LP | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −10,825−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,775−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −7,085−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −3,380−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −2,347−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,305−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| LRI Investments, LLC | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Financial Consulate, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| AXA Investment Managers S.A. | – | – | – | – | Not filed |